Discovery of human cardiac myosin regulatory sites, modulating cross-bridge kinetics in heart muscle
发现人类心肌肌球蛋白调节位点,调节心肌的跨桥动力学
基本信息
- 批准号:9098891
- 负责人:
- 金额:$ 44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-05 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAffectAnimal ModelBindingBinding SitesCardiacCardiac MyosinsChargeComputer SimulationDataDevelopmentElectrostaticsExhibitsFailureGenesGoalsHeadHeartHeart failureHumanKineticsKnowledgeLeadLearningLeft ventricular structureMolecularMolecular ConformationMolecular MotorsMuscleMuscle functionMutagenesisMutationMyocardiumMyosin ATPaseMyosin Heavy ChainsN-terminalNucleotidesOryctolagus cuniculusOutputPerformancePositioning AttributeProductionPropertyProtein IsoformsRattusRecombinantsResearchSiteSite-Directed MutagenesisStructureSystemTestingTherapeuticTransgenic OrganismsWorkabstractingadenoviral-mediatedbasebeta-Myosincrosslinkdrug developmentexperimental analysisimprovedinsightmeltingmolecular dynamicsmutantnovel therapeuticspublic health relevanceresearch studyskeletal
项目摘要
DESCRIPTION (provided by applicant): Abstract Healthy human cardiac muscle is composed of two myosin isoforms, alpha and beta, which are significantly different in kinetics of the cross-bridge cycle. The specific myosin isoform composition tunes muscle for maximum performance, force production, power output, and economy. The mechanisms behind this fine muscle's performance tune-up are not known, thus limiting our understanding of a fundamental muscle property. Our long-term goal is to apply insights gained from learning the origin of kinetic differences of cardiac myosin isoforms to help devise ways to restore impaired muscle function. We envision tune-up of failed heart muscle by mimicking the healthy muscle isoform composition. The immediate objective of this proposal is to elucidate the molecular mechanism of kinetic difference of cardiac myosin isoforms. Our central hypothesis is that isoform kinetics i determined by the electrostatic interactions at the regulatory site within myosin head. Our hypothesis is based on a significant body of experimental data, confirming possibility of myosin kinetics modulation. Three specific aims are to validate our hypothesis. The specific aims are focused on potential regulatory sites within different parts of myosin head, Loop1 (Aim 1), upper 50 kDa domain (Aim 2), and the force generating region (Aim 3). According to our working hypothesis, these regulatory sites modulate myosin-nucleotide interaction, including the rate of ADP release from the cross-bridge, which is the rate limiting step of the slow beta myosin isoform. We plan to use site specific mutagenesis, altering electrostatic interactions within proposed regulatory sites. We will prepare mutants of recombinant human cardiac beta myosin and will characterize kinetics of prepared myosin mutants. We will examine our hypothesis on importance of electrostatic interactions within proposed regulatory sites on myosin kinetics modulation. The proposed research is significant because it will provide a detailed understanding of the mechanism by which human cardiac muscle is fine tuned for maximum performance. We will gain new insights into fundamental mechanisms by which produced force and power, and muscle energetics are modulated by muscle isoform composition. Elucidating kinetic tune-up mechanisms may lead to therapeutic ways of restoring or improving muscle function.
描述(由申请人提供):摘要健康的人类心肌由两种肌球蛋白亚型(α 和 β)组成,它们的跨桥循环动力学显着不同,特定的肌球蛋白亚型成分可调节肌肉以获得最大性能、力量产生、这种精细肌肉的性能调节背后的机制尚不清楚,因此限制了我们对基本肌肉特性的理解,我们的长期目标是应用从学习动力学起源中获得的见解。我们设想通过模仿健康肌肉同种型的组成来调整衰竭的心肌,该提案的直接目标是阐明心肌肌球蛋白动力学差异的分子机制。我们的中心假设是,同种型动力学是由肌球蛋白头部调节位点的静电相互作用决定的。我们的假设基于大量实验数据,证实了肌球蛋白的可能性。三个具体目标是验证我们的假设,具体目标集中在肌球蛋白头、Loop1(目标 1)、上 50 kDa 结构域(目标 2)和力产生区域(目标)内的潜在调节位点。 3)根据我们的工作假设,这些调节位点调节肌球蛋白-核苷酸相互作用,包括ADP从跨桥释放的速率,这是慢β肌球蛋白亚型的限速步骤。计划使用位点特异性诱变,改变拟议的调节位点内的静电相互作用我们将制备重组人心脏β肌球蛋白的突变体,并将表征所制备的肌球蛋白突变体的动力学我们将检查我们关于肌球蛋白上拟议的调节位点内静电相互作用的重要性的假设。所提出的研究意义重大,因为它将提供对人类心肌微调以获得最大性能的机制的详细了解,我们将对产生力和功率以及肌肉的基本机制获得新的见解。能量学是由肌肉亚型组成调节的,阐明动力学调节机制可能会导致恢复或改善肌肉功能的治疗方法。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Local Environment of Loop Switch 1 Modulates the Rate of ATP-Induced Dissociation of Human Cardiac Actomyosin.
环路开关 1 的局部环境调节 ATP 诱导的人心脏肌动球蛋白解离速率。
- DOI:
- 发表时间:2022-01-22
- 期刊:
- 影响因子:5.6
- 作者:Gargey, Akhil;Nesmelov, Yuri E
- 通讯作者:Nesmelov, Yuri E
CaATP prolongs strong actomyosin binding and promotes futile myosin stroke.
CaATP 可延长肌动球蛋白的强结合并促进无效性肌球蛋白中风。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:2.7
- 作者:Ge, Jinghua;Gargey, Akhil;Nesmelova, Irina V;Nesmelov, Yuri E
- 通讯作者:Nesmelov, Yuri E
Electrostatic interactions in the force-generating region of the human cardiac myosin modulate ADP dissociation from actomyosin.
人心肌肌球蛋白力产生区域的静电相互作用调节 ADP 与肌动球蛋白的解离。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:3.1
- 作者:Gargey, Akhil;Ge, Jinghua;Tkachev, Yaroslav V;Nesmelov, Yuri E
- 通讯作者:Nesmelov, Yuri E
Metal cation controls phosphate release in the myosin ATPase.
金属阳离子控制肌球蛋白 ATP 酶中磷酸盐的释放。
- DOI:
- 发表时间:2017-11
- 期刊:
- 影响因子:0
- 作者:Ge, Jinghua;Huang, Furong;Nesmelov, Yuri E
- 通讯作者:Nesmelov, Yuri E
Electrostatic interaction of loop 1 and backbone of human cardiac myosin regulates the rate of ATP induced actomyosin dissociation.
环 1 和人心肌肌球蛋白骨架的静电相互作用调节 ATP 诱导的肌动球蛋白解离速率。
- DOI:
- 发表时间:2022-03
- 期刊:
- 影响因子:2.7
- 作者:Gargey, Akhil;Nesmelov, Yuri E
- 通讯作者:Nesmelov, Yuri E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YURI NESMELOV其他文献
YURI NESMELOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YURI NESMELOV', 18)}}的其他基金
Post translational modifications tune cardiac myosin
翻译后修饰调节心肌肌球蛋白
- 批准号:
10291447 - 财政年份:2021
- 资助金额:
$ 44万 - 项目类别:
The Mechanism of Myosin ATPase Actin Activation
肌球蛋白 ATP 酶肌动蛋白激活机制
- 批准号:
7939094 - 财政年份:2010
- 资助金额:
$ 44万 - 项目类别:
Functional Dynamics of the Myosin Molecular Motor
肌球蛋白分子马达的功能动力学
- 批准号:
7077227 - 财政年份:2006
- 资助金额:
$ 44万 - 项目类别:
Functional Dynamics of the Myosin Molecular Motor
肌球蛋白分子马达的功能动力学
- 批准号:
7582431 - 财政年份:2006
- 资助金额:
$ 44万 - 项目类别:
Functional Dynamics of the Myosin Molecular Motor
肌球蛋白分子马达的功能动力学
- 批准号:
7216844 - 财政年份:2006
- 资助金额:
$ 44万 - 项目类别:
Functional Dynamics of the Myosin Molecular Motor
肌球蛋白分子马达的功能动力学
- 批准号:
7920570 - 财政年份:2006
- 资助金额:
$ 44万 - 项目类别:
Functional Dynamics of the Myosin Molecular Motor
肌球蛋白分子马达的功能动力学
- 批准号:
7391671 - 财政年份:2006
- 资助金额:
$ 44万 - 项目类别:
Enhanced EPR Sensitivity for Biomedical Research
增强生物医学研究的 EPR 敏感性
- 批准号:
6941301 - 财政年份:2003
- 资助金额:
$ 44万 - 项目类别:
Enhanced EPR Sensitivity for Biomedical Research
增强生物医学研究的 EPR 敏感性
- 批准号:
6792215 - 财政年份:2003
- 资助金额:
$ 44万 - 项目类别:
Enhanced EPR Sensitivity for Biomedical Research
增强生物医学研究的 EPR 敏感性
- 批准号:
6675191 - 财政年份:2003
- 资助金额:
$ 44万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.
用于口服治疗顽固性结节性痤疮的选择性 CYP26 抑制剂。
- 批准号:
10822482 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
心力衰竭的新型疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:
10599654 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Chemical proteomic investigation of lipid kinase specificity and druggability
脂质激酶特异性和成药性的化学蛋白质组学研究
- 批准号:
10660099 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Modulating Fibrinolysis Dynamics by Leveraging Multivalent Avidity to Control Enzyme Activity
通过利用多价亲和力控制酶活性来调节纤维蛋白溶解动力学
- 批准号:
10635496 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别: